CiberMed
CiberMed is a biotechnology company pioneering digital cytometry with its AI-powered platform, iSort™. Founded by Stanford professors and industry veterans, CiberMed offers iSort™ as an industrial-grade solution for high-resolution cellular profiling and biomarker discovery. The platform provides an accurate, high throughput, and low-cost alternative for determining cell type composition, applicable across various disease areas such as cancer and autoimmune diseases. Trusted by leading pharmaceutical companies, diagnostic companies, and academic researchers, CiberMed's technology aims to unlock new potential in life sciences research by accelerating biomarker discovery.
CiberMed
CiberMed is a biotechnology company pioneering digital cytometry with its AI-powered platform, iSort™. Founded by Stanford professors and industry veterans, CiberMed offers iSort™ as an industrial-grade solution for high-resolution cellular profiling and biomarker discovery. The platform provides an accurate, high throughput, and low-cost alternative for determining cell type composition, applicable across various disease areas such as cancer and autoimmune diseases. Trusted by leading pharmaceutical companies, diagnostic companies, and academic researchers, CiberMed's technology aims to unlock new potential in life sciences research by accelerating biomarker discovery.